An Effectiveness and Safety 6 Months Study of 3 Injections One Week Apart of SYNOLIS VA 40/80 in the Treatment of Symptomatic Knee Osteoarthritis

NCT05829850 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 51

Last updated 2023-04-26

No results posted yet for this study

Summary

Multicentre, independent assessment study on SYNOLIS VA 40/80 over a period of 24 weeks

Conditions

  • Osteo Arthritis Knee

Interventions

DEVICE

SYNOLIS VA 40/80

Three 2mL injections of SYNOLIS VA 40/80, one week apart

Sponsors & Collaborators

  • Noblewell

    collaborator INDUSTRY
  • Aptissen SA

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
35 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-29
Primary Completion
2023-01-09
Completion
2023-01-09

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05829850 on ClinicalTrials.gov